Atlas Trials

Single-Dose Escalation Study of IDX184 in Healthy Volunteers (MK-2355-002)

Clinical trial NCT00730431 · COMPLETED

Trial details

NCT number
NCT00730431
Sponsor
Merck Sharp & Dohme LLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatitis C
Start date
2008-07-01
Primary completion
2008-10-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.